Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits

NCT04419272 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

226

Enrollment

FED

Sponsor class

Conditions

Epilepsy

Interventions

DRUG: Methylphenidate
OTHER: Placebo
DRUG: Methylphenidate

Sponsor

VA Office of Research and Development

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]